Brr Op Co, LLC Bristol Myers Squibb CO Transaction History

Brr Op Co, LLC

$815 Million
Q3 2022

A detailed history of Brr Op Co, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Brr Op Co, LLC holds 56,460 shares of BMY stock, worth $2.87 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

56,460

Previous 58,039 2.72%

Holding current value

$2.87 Million

Previous $4.47 Million 10.18%

% of portfolio

0.49%

Previous 0.53%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $205 - $121,330	-1,579 Reduced 2.72%	56,460 $4.01 Million
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $129,118 - $142,204	1,778 Added 3.16%	58,039 $4.47 Million
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $2,828 - $3,391	46 Added 0.08%	56,261 $4.11 Million
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $328,644 - $383,122	6,128 Added 12.23%	56,215 $3.51 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $101,358 - $118,728	1,713 Added 3.54%	50,087 $2.96 Million
Q2 2021 Aug 09, 2021	BUY	$61.91 - $67.42 $60,424 - $65,801	976 Added 2.06%	48,374 $3.23 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $3,441 - $3,870	58 Added 0.12%	47,398 $2.99 Million
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $86,783 - $98,341	1,503 Added 3.28%	47,340 $2.94 Million
Q3 2020 Nov 03, 2020	BUY	$57.43 - $63.64 $70,524 - $78,149	1,228 Added 2.75%	45,837 $2.76 Million
Q2 2020 Feb 14, 2022	BUY	$54.82 - $64.09 $17,487 - $20,444	319 Added 0.72%	44,609 $2.62 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $110,626 - $129,333	2,018 Added 4.77%	44,290 $2.6 Million
Q1 2020 Feb 14, 2022	BUY	$46.4 - $67.43 $14,801 - $21,510	319 Added 0.76%	42,272 $2.36 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $10,811 - $15,711	-233 Reduced 0.55%	41,953 $2.34 Million
Q4 2019 Feb 14, 2022	BUY	$49.21 - $64.19 $2.08 Million - $2.71 Million	42,186 New	42,186 $2.71 Million
Q4 2019 Jan 31, 2020	SELL	$49.21 - $64.19 $1.86 Million - $2.43 Million	-37,838 Closed	0 $0
Q3 2019 Feb 14, 2022	BUY	$42.77 - $50.71 $1.62 Million - $1.92 Million	37,838 New	37,838 $1.92 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $1.61 Million - $1.9 Million	-37,532 Closed	0 $0
Q2 2019 Feb 14, 2022	BUY	$44.62 - $49.34 $1.67 Million - $1.85 Million	37,532 New	37,532 $1.7 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $999,041 - $1.1 Million	-22,390 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$45.12 - $53.8 $42,367 - $50,518	939 Added 4.38%	22,390 $1.07 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $8,240 - $10,685	-169 Reduced 0.78%	21,451 $1.12 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $10,430 - $11,765	-189 Reduced 0.87%	21,620 $1.34 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $10,965 - $13,666	-217 Reduced 0.99%	21,809 $1.21 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $22,709 - $26,143	-379 Reduced 1.69%	22,026 $1.39 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $14,205 - $15,487	-237 Reduced 1.05%	22,405 $1.37 Million
Q3 2017 Nov 09, 2017	SELL	$55.23 - $63.74 $30,100 - $34,738	-545 Reduced 2.35%	22,642 $1.44 Million
Q2 2017 Aug 09, 2017	BUY	N/A	23,187	23,187 $1.29 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brr Op Co, LLC with notifications on news.

Account